Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Neuroscience Neurotransmission Intracellular Signaling Kinases

Recombinant human GST-Nucleoplasmin ALK (mutated F1174L) fusion protein (Active) (ab268819)

Recombinant human GST-Nucleoplasmin ALK (mutated F1174L) fusion protein (Active) (ab268819)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Expression system: Sf9 cells
  • Purity: > 70% SDS-PAGE
  • Active: Yes
  • Tags: GST tag N-Terminus
  • Suitable for: SDS-PAGE, Functional Studies

You may also be interested in

Product image
Anti-AL-1 antibody (ab262837)
Product image
Recombinant human ROCK2 protein (ab125828)
Product image
Human CDK17 (PCTAIRE2) knockout HeLa cell lysate (ab263144)
Product image
Anti-PPM1F/POPX2 antibody (ab200394)

Description

  • Product name

    Recombinant human GST-Nucleoplasmin ALK (mutated F1174L) fusion protein (Active)
  • Biological activity

    The specific activity of ab268819 was determined to be 8 nmol/min/mg in a kinase assay using IGF1Rtide synthetic peptide substrate.

  • Purity

    > 70 % SDS-PAGE.

  • Expression system

    Sf9 cells
  • Accession

    P06748
    Q9UM73
  • Protein length

    Protein fragment
  • Animal free

    No
  • Nature

    Recombinant
    • Amino Acid Sequence 1

    • Species

      Human
    • Molecular weight information

      Approx 108 kDa by SDS-PAGE (GST-Nucleoplasmin-ALK (F1174L) fusion protein)
    • Amino acids

      1 to 117
    • Tags

      GST tag N-Terminus
    • Additional sequence information

      Genbank: U04946
    • Amino Acid Sequence 2

    • Species

      Human
    • Sequence

      1058-end
    • Molecular weight information

      Approx 108 kDa by SDS-PAGE (GST-Nucleoplasmin-ALK (F1174L) fusion protein).
    • Modifications

      mutated F1174L
    • Additional sequence information

      Genbank: U04946
  • Description

    Recombinant human ALK (mutated F1174L) + Nucleophosmin protein (Tagged)

Preparation and Storage

  • Applications

    SDS-PAGE

    Functional Studies

  • Form

    Liquid
  • Additional notes

    GST-Nucleoplasmin-ALK (F1174L) fusion protein.

  • Concentration information loading...

Images

  • Functional Studies - Recombinant human GST-Nucleoplasmin ALK (mutated F1174L) fusion protein (Active) (ab268819)
    Functional Studies - Recombinant human GST-Nucleoplasmin ALK (mutated F1174L) fusion protein (Active) (ab268819)

    The specific activity of ab268819 was determined to be 8 nmol/min/mg in a kinase assay using IGF1Rtide synthetic peptide substrate.

  • SDS-PAGE - Recombinant human GST-Nucleoplasmin ALK (mutated F1174L) fusion protein (Active) (ab268819)
    SDS-PAGE - Recombinant human GST-Nucleoplasmin ALK (mutated F1174L) fusion protein (Active) (ab268819)

    SDS-PAGE analysis of ab268819.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Goat Anti-Mouse IgG2b heavy chain (HRP) preadsorbed (ab98703)

  •  
  • Recombinant HIV1 integrase protein (ab49082)

  •  
  • Product image

    Human PTPRM knockout HeLa cell line (ab265846)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.